Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1632 1638 1651
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18802201 | NON-HUMAN ANIMALS HAVING A HUMANIZED LYMPHOCYTE-ACTIVATION GENE 3 | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 18711180 | FEED COMPOSITION FOR CONSTRUCTION OF STEATOHEPATITIS ANIMAL MODEL | Non-Final OA | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY |
| 19257274 | METHOD FOR IN VITRO GENERATION OF HUMAN SPERMATIDS | Non-Final OA | PATERNA BIOSCIENCES INC. |
| 18513051 | CELL AND COLLAGEN COMPOSITIONS FOR ENGINEERED CARDIAC TISSUE | Non-Final OA | BROWN UNIVERSITY |
| 18808470 | METHOD FOR EVALUATING BIOLOGICAL ACTIVITY OF BIOMATERIALS | Non-Final OA | Axogen Corporation |
| 18598152 | CARDIAC ORGANOID AND ANTI-ELECTRO-MITOCHONDRIAL DESYNCHRONIZATION THERAPY | Non-Final OA | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy